Integral Health Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-234,830
| Closed | -$2.28M | – | 72 |
|
|
2022
Q2 | $2.28M | Buy |
234,830
+63,830
| +37% | +$619K | 0.47% | 56 |
|
|
2022
Q1 | $1.7M | Buy |
171,000
+31,000
| +22% | +$308K | 0.44% | 57 |
|
|
2021
Q4 | $1.65M | Buy |
+140,000
| New | +$1.65M | 0.46% | 57 |
|
|
2021
Q1 | – | Sell |
-135,000
| Closed | -$2.39M | – | 82 |
|
|
2020
Q4 | $2.39M | Buy |
135,000
+15,000
| +13% | +$265K | 0.71% | 43 |
|
|
2020
Q3 | $1.84M | Buy |
+120,000
| New | +$1.84M | 0.56% | 58 |
|